Yerxa Benjamin R

Yerxa Benjamin R is listed in filings as President at Opus Genetics, Inc.. This profile follows SEC Form 4 activity through Apr 27, 2026, including sale activity and purchase activity. Recent filings connect the profile to Opus Genetics, Inc. (IRD) and Clearside Biomedical, Inc. (CLSDQ). The current snapshot covers public activity from Jun 21, 2024 to Apr 27, 2026. Reported amounts are shown as $39.1K to $9.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.